View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAgroFresh Solutions 将来の成長Future 基準チェック /06主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長38.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジLow最終更新日31 Mar 2023今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • Mar 30High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 15Full year 2022 earnings released: US$1.15 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$1.15 loss per share (further deteriorated from US$0.59 loss in FY 2021). Revenue: US$161.9m (down 2.4% from FY 2021). Net loss: US$59.8m (loss widened 97% from FY 2021).Board Change • Mar 15High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Feb 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 29High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 11Third quarter 2022 earnings released: US$0.079 loss per share (vs US$0.10 loss in 3Q 2021)Third quarter 2022 results: US$0.079 loss per share (improved from US$0.10 loss in 3Q 2021). Revenue: US$47.8m (down 2.9% from 3Q 2021). Net loss: US$4.14m (loss narrowed 21% from 3Q 2021). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 8.9% decline forecast for the Chemicals industry in the United Kingdom.Buying Opportunity • Nov 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be US$3.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 24% per annum over the same time period.Board Change • Oct 27High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • May 13First quarter 2022 earnings released: US$0.18 loss per share (vs US$0.029 profit in 1Q 2021)First quarter 2022 results: US$0.18 loss per share (down from US$0.029 profit in 1Q 2021). Revenue: US$39.9m (up 2.3% from 1Q 2021). Net loss: US$9.52m (down US$11.0m from profit in 1Q 2021). Over the next year, revenue is forecast to grow 6.5% compared to a 18% decline forecast for the industry in the United Kingdom.Board Change • May 12High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.59 loss per share (up from US$1.27 loss in FY 2020). Revenue: US$166.0m (up 5.3% from FY 2020). Net loss: US$30.3m (loss narrowed 53% from FY 2020). Revenue exceeded analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 6.1% compared to a 12% decline forecast for the industry in the United Kingdom.Board Change • Mar 10High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Jan 12High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 17High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 11Third quarter 2021 earnings released: US$0.10 loss per share (vs US$0.52 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: US$49.2m (down 6.8% from 3Q 2020). Net loss: US$5.25m (loss narrowed 80% from 3Q 2020).Board Change • Nov 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • May 17First quarter 2021 earnings released: EPS US$0.047 (vs US$0.074 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$39.0m (up 18% from 1Q 2020). Net income: US$2.42m (up US$6.14m from 1Q 2020). Profit margin: 6.2% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 36 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 12Full year 2020 earnings released: US$1.26 loss per share (vs US$1.21 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$157.6m (down 7.3% from FY 2019). Net loss: US$64.2m (loss widened 5.5% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 84% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 5.9% compared to a 8.5% decline forecast for the Chemicals industry in the United Kingdom.業績と収益の成長予測LSE:0HB7 - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2023181-331939212/31/2022162-601216N/A9/30/2022169-491923N/A6/30/2022171-432125N/A3/31/2022167-412731N/A12/31/2021166-304852N/A9/30/2021162-365053N/A6/30/2021166-654648N/A3/31/2021164-594749N/A12/31/2020158-642427N/A9/30/2020167-772528N/A6/30/2020163-392123N/A3/31/2020164-451012N/A12/31/2019170-541620N/A9/30/2019162-34811N/A6/30/2019182-34913N/A3/31/2019179-3049N/A12/31/2018179-30-13N/A9/30/2018180-5-34N/A6/30/20181722715N/A3/31/2018170232130N/A12/31/2017164232835N/A9/30/2017162-684551N/A6/30/2017162-713339N/A3/31/2017164-982329N/A12/31/2016160-1122430N/A9/30/2016159-43N/A31N/A6/30/2016160-65N/A35N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0HB7の予測収益成長が 貯蓄率 ( 1.2% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 0HB7の収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 0HB7の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 0HB7の収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 0HB7の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0HB7の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/04/03 01:50終値2023/03/30 00:00収益2022/12/31年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋AgroFresh Solutions, Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Joel JacksonBMO Capital Markets Equity ResearchAmit DayalH.C. Wainwright & Co.Benjamin KlieveLake Street Capital Markets, LLC1 その他のアナリストを表示
Board Change • Mar 30High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 15Full year 2022 earnings released: US$1.15 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$1.15 loss per share (further deteriorated from US$0.59 loss in FY 2021). Revenue: US$161.9m (down 2.4% from FY 2021). Net loss: US$59.8m (loss widened 97% from FY 2021).
Board Change • Mar 15High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Feb 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 29High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 11Third quarter 2022 earnings released: US$0.079 loss per share (vs US$0.10 loss in 3Q 2021)Third quarter 2022 results: US$0.079 loss per share (improved from US$0.10 loss in 3Q 2021). Revenue: US$47.8m (down 2.9% from 3Q 2021). Net loss: US$4.14m (loss narrowed 21% from 3Q 2021). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 8.9% decline forecast for the Chemicals industry in the United Kingdom.
Buying Opportunity • Nov 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be US$3.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 24% per annum over the same time period.
Board Change • Oct 27High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 13First quarter 2022 earnings released: US$0.18 loss per share (vs US$0.029 profit in 1Q 2021)First quarter 2022 results: US$0.18 loss per share (down from US$0.029 profit in 1Q 2021). Revenue: US$39.9m (up 2.3% from 1Q 2021). Net loss: US$9.52m (down US$11.0m from profit in 1Q 2021). Over the next year, revenue is forecast to grow 6.5% compared to a 18% decline forecast for the industry in the United Kingdom.
Board Change • May 12High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.59 loss per share (up from US$1.27 loss in FY 2020). Revenue: US$166.0m (up 5.3% from FY 2020). Net loss: US$30.3m (loss narrowed 53% from FY 2020). Revenue exceeded analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 6.1% compared to a 12% decline forecast for the industry in the United Kingdom.
Board Change • Mar 10High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Jan 12High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 17High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 11Third quarter 2021 earnings released: US$0.10 loss per share (vs US$0.52 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: US$49.2m (down 6.8% from 3Q 2020). Net loss: US$5.25m (loss narrowed 80% from 3Q 2020).
Board Change • Nov 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 17First quarter 2021 earnings released: EPS US$0.047 (vs US$0.074 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$39.0m (up 18% from 1Q 2020). Net income: US$2.42m (up US$6.14m from 1Q 2020). Profit margin: 6.2% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 36 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 12Full year 2020 earnings released: US$1.26 loss per share (vs US$1.21 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$157.6m (down 7.3% from FY 2019). Net loss: US$64.2m (loss widened 5.5% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 84% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 5.9% compared to a 8.5% decline forecast for the Chemicals industry in the United Kingdom.